Why freezing flower minutes after harvest changes extraction, pricing, and delivery—and how DMV founders and investors can build solventless businesses that actually scale.

Schedule III didn’t unlock banking. One credit union’s model shows how cannabis businesses get compliant access to payments—plus what DMV operators should watch next.

A seasoned finance leader steps in at Village Farms. Here’s how a CFO transition can shape cannabis delivery models, investor strategy, and DMV business opportunities.

Red White & Bloom secures a controlling European foothold spanning Germany and the UK, adding pharmacy logistics, clinics, and 290,000 annual prescriptions to its portfolio.

New NCIA data shows pre-rolls dominate consumer spend. Here’s how that reshapes cannabis delivery business models, DMV opportunities, and investor risk in 2026.

A federal appeals court left the Attorney General’s limited Schedule III move in place as Congress bickers over hemp. Here’s what DMV delivery operators and consumers should watch now.

Headset Inc. will make staged payments through 2030 to settle allegations it improperly received a federal PPP loan because of its cannabis industry ties.

Under SB 3222, Illinois adult-use retailers can apply for medical cannabis licenses—opening the door to DEA eligibility and potential 280E relief, per MJBizDaily.

A clear, step-by-step 2026 guide to spotting healthy cannabis seeds, planning your grow timeline, and sourcing wisely—plus DMV business angles and risks to watch.

A sophisticated RFP-themed phishing campaign is hitting cannabis companies. Here’s how delivery operators, investors, and DMV entrepreneurs can protect revenue and assess risk now.

People seek ways to pause a difficult psychedelic experience. Psychedelic Science Review spotlights ketanserin’s promise. Here’s what’s known, what isn’t, and harm-reduction context for DMV readers.

Operational change is the earliest safety-and-cost signal in cannabis logistics. Here’s how delivery operators and investors can turn risk awareness into business edge.

Psychedelic Alpha’s Issue 6, “Preparedness (People),” spotlights the human side of readiness. Here’s a practical, people-first framework with DMV context and next steps.

Prosecutors say raids on six Hemp 1848 stores uncovered high-THC items labeled as legal hemp; the owner denies the charges as his attorney contests the case.

Researchers have experimentally shown that psilacetin (4‑AcO‑DMT) converts to psilocin in animals, resolving a long-running question about its metabolic fate.

Psychedelic Alpha reports that Risk Evaluation and Mitigation Strategies are likely to shape how FDA-approved psychedelic therapies are delivered. Here’s what to watch.